Home
Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Hold... Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domainpernixtx.com

Year Founded1996

Employees201 - 500

Annual Revenue$100M - $200M

Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Holdings, Inc. (including company regionals)

pernixtx.com

See more website traffic and engagement information

Pernix Therapeutics Holdings, Inc. Revenue up to May 2026 is 100M - 200M

revenue generated by Pernix Therapeutics Holdings, Inc. top domains

Pernix Therapeutics Holdings, Inc. top domains revenue over 3 years

Revenue for Pernix Therapeutics Holdings, Inc. top domains

pernixtx.com100M - 200M

See more with Sales Intelligence

Total visits to Pernix Therapeutics Holdings, Inc.'s top domains

Understand Pernix Therapeutics Holdings, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Pernix Therapeutics Holdings, Inc.'s top domains

Analyze Pernix Therapeutics Holdings, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Pernix Therapeutics Holdings, Inc.'s top domains

See how Pernix Therapeutics Holdings, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Pernix Therapeutics Holdings, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

collegiumpharma.comCompany NameCollegium PharmaceuticalEmployees201 - 500HQUnited States, Massachusetts, StoughtonAnnual revenue$500M - $1BTotal visits15.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Pernix Therapeutics Holdings, Inc.

These are the website technologies, by industry, used by Pernix Therapeutics Holdings, Inc. top domains

Advertising (2)

Google Adsense

Conversion & Analytics (2)

Google Analytics

Email Services (2)

GoDaddy Email

Mobile (2)

Meta Viewport

More Technologies

3

See all

News & Signals from Pernix Therapeutics Holdings, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPernixtx acquired Somaxon Pharmaceuticals, Inc. for $25M on Jan 1st '14.Pernix Therapeutics (NYSE:PTX) to acquire Somaxon (SOMX); $25 million accord – PTX, CRME, DEPO, AGN, DVAX, AMRN, ALXA, PFE, JNJ.

NewsPernixtx has issues with Chapter 11 bankruptcy.The sale was consummated through Pernix’s Chapter 11 bankruptcy.

NewsPernixtx partners with Highbridge Capital Management LLC.Pernix has entered into an asset purchase agreement with debt holder Highbridge Capital Management.